Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...
New data shows that men are still more likely than women to be diagnosed with diabetes in the U.S., rates of the disease have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback